Royce & Associates Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
CORE
Core Mark Holding Co., Inc.
CORE
|
+$24M |
| 2 |
Manhattan Associates
MANH
|
+$21.1M |
| 3 |
MDSO
Medidata Solutions, Inc.
MDSO
|
+$19.9M |
| 4 |
Camping World
CWH
|
+$19.3M |
| 5 |
AL
Air Lease Corp
AL
|
+$17.8M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MKS Inc
MKSI
|
+$35.5M |
| 2 |
Woodward
WWD
|
+$35M |
| 3 |
Copart
CPRT
|
+$22.9M |
| 4 |
BGC
General Cable Corporation
BGC
|
+$22.7M |
| 5 |
ORBK
Orbotech Ltd
ORBK
|
+$22.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 28.26% |
| 2 | Technology | 16.98% |
| 3 | Consumer Discretionary | 14.15% |
| 4 | Financials | 11.65% |
| 5 | Materials | 6.5% |
Similar funds
Royce & Associates's Q1 2018 Portfolio in Review
As of Q1 2018, Royce & Associates held 1,329 positions worth $14.3B, down 4.9% from $15B the previous quarter. Its ten largest holdings account for 8.4% of the portfolio.
Royce & Associates withdrew a net $494M in Q1 2018, closing 75 positions and reducing 492 holdings. Its most notable exit was Sucampo Pharmaceuticals, Inc., an estimated $15.8M position sold in full.
By sector, the portfolio is most concentrated in Industrials at 28% of assets, down from 28% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, Royce & Associates opened a new position in PotlatchDeltic worth $12M.
- Royce & Associates's largest Q1 2018 buy was PotlatchDeltic: 230,008 shares worth $12M.
- Royce & Associates added most to Core Mark Holding Co., Inc. in Q1 2018, an estimated $24M increase.
- Royce & Associates's biggest Q1 2018 reduction was MKS Inc, cutting an estimated $35.5M.
- Royce & Associates fully exited Sucampo Pharmaceuticals, Inc. in Q1 2018, selling an estimated $15.8M.
- Royce & Associates's ten largest holdings make up 8.4% of its $14.3B portfolio in Q1 2018.
- Royce & Associates opened 83 new positions and closed 75 in Q1 2018.
- Royce & Associates's portfolio value fell 4.9% quarter-over-quarter to $14.3B.
Based on Royce & Associates's 13F filing for Q1 2018, filed 14 May 2018.